INTRODUCTION
Obesity has become the most common metabolic disorder in the developed world. 1 Currently, 54.9% of the US population is considered overweight by body mass index criteria whereas 22.5% is considered obese. 2 Fatty livers are commonly observed among obese individuals, 3 with incidence rate of 60-90% among morbidly obese individuals. 4 Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of a broad metabolic syndrome that includes variably defined disorders related to obesity, insulin resistance, type-2 diabetes, hypertension and dyslipidemia. 5 In the early stages of NAFLD, triglycerides accumulate in hepatocytes. The presence of liver steatosis is a risk factor for the progression of NAFLD to more advanced stages such as non-alcoholic steatohepatitis (NASH) that is accompanied by oxidative stress, inflammation and cell death. [6] [7] [8] [9] Cytokines are pleiotropic regulatory peptides that can be produced upon physiopathological stimulation of most nucleated cells. 10 There is increasing evidence that several cytokines regulate metabolism, inflammatory response, cell death, regeneration and fibrogenesis in normal and injured liver tissue. 11 Obesity is characterized by a broad, subacute, inflammatory response and many inflammatory mediators exhibit patterns of expression and/or impact insulin action that correlate with the progression of metabolic syndrome. [12] [13] [14] [15] Nevertheless, whether cytokines are associated with the induction of fatty liver, insulin resistance or liver injury has not been fully clarified. Paradoxically, though interleukin (IL)-6 is a prognostic factor of hepatic steatosis in obese morbid 16 and NASH 17 patients, IL-6 has been suggested to mediate pharmacological reduction of hepatic steatosis. 18 The primary purpose of the present study was to evaluate the association of peripheral IL-6 concentrations with the progression of fatty liver, lipid imbalance, and liver injury in a nutritional model of liver steatosis, the choline-deficient (CD) diet fed rat. Because correlation was found between triglyceride accumulation, reduction in membrane integrity markers and IL-6 levels in this model, a secondary objective was to identify potential mechanisms for this effect in isolated hepatocytes. We found elevated IL-6 receptor mRNA expression in steatotic hepatocytes and in non-steatotic cells after IL-6-rich serum treatment. We also found that IL-6 reversed most of the mitochondrial disturbances in lipid composition associated with steatosis while it did not improve cell death susceptibility. Remarkably, phosphatidylcholine (PC) was identified as a new factor that reverses tumornecrosis factor (TNF)-a-inducible responses that are likely to promote fatty liver disease progression and necrosis.
MATERIALS AND METHODS

Animals
Male Wistar rats (n ¼ 70; 225-275 g) were housed under controlled light/dark cycle and free access to chow and drinking water. Liver steatosis was induced by feeding an isocaloric choline-deficient (CD) methionine sufficient diet (15% fat; Dyets Inc., Bethlehem, PA, USA; Table 1 ). In the first set of experiments, animals were sacrificed at 3, 7, 14, 28 or 42 d (n ¼ 6 rats/group) after 18-h starvation. In a second set of experiments using isolated hepatocytes, animals (n ¼ 5 rats/group) were used after 3 d of control or CD feeding. Cholinedeficient diet is a nutritional model of hepatic steatosis characterized by microvesicular steatosis without NASH features. 19 The procedures followed were in accordance with the institutional guidelines for the care and use of laboratory animals.
Determination of serum TNF-a, IL-6 and biochemistry
Interleukin-6 and TNF-a were measured by commercial ELISA following the manufacturer's instructions (Biosource International, Camarillo, CA, USA). The detection ranges for the IL-6 assays was 31.2-2000 pg/ ml and for the TNF-a assays 2.3-150 pg/ml. Alanine aminotransferase (ALT), glucose and insulin levels in serum were measured using automatic procedures (Axon Bayer Diagnostic, Tarrytown, NY, USA).
Hepatic histology
Liver samples were fixed in 10% formalin, embedded in paraffin, and sections (5 mm) were obtained for the histological evaluation by hematoxylin-eosin staining, cell death by TUNEL (R&D Systems, Minneapolis, MN, USA). Hepatic steatosis by oil red staining was assessed in sections obtained from pieces of liver included in tissue-tek OCT compound. Immunohistochemistry for TNF-a was performed in liver deparaffinised fixed sections (3 mm) pre-treated with 3% H 2 O 2 for 30 min and then with 1% fetal bovine serum and 10% rat serum for 1 h to eliminate endogenous peroxadises and nonspecific immunostaining, respectively. Liver sections were incubated with primary goat anti-rat TNF-a antibodies (R&D Systems) for 12 h at 4 C and secondary biotinylated polyclonal anti-goat IgG antibodies (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA) for 1 h at 37 C. Negative immunostaining for each sample was evaluated using non-specific polyclonal goat antibodies. Sections were incubated with 
Isolation and culture of hepatocytes
Hepatocytes were isolated from rats fed a control or a CD diet for 3 d by a non-recirculating in situ collagenase perfusion of livers. 20 Cell isolation from animals with advanced stages of liver steatosis yielded hepatocytes with reduced cell viability that limited their use for cell culture. Viability of CD and control hepatocytes ranged from 75-85% as assessed by Trypan blue exclusion test. The hepatocytes isolated from animals on control diet were cultured in control William's medium E (Applichem, Darmstadt, Germany). The hepatocytes isolated from animals on CD diet were cultured in CD William's medium E (Applichem). Hepatocytes (150,000 cells/cm 2 ) were seeded in type I collagencoated dishes (Iwaki, Gyouda, Japan) in medium with 5% fetal bovine serum for 2 h, and further allowed to stabilize for 24 h without bovine serum. The effect of IL-6 on hepatocyte cell death induced by TNF-a (10 ng/ml) and actinomycin A (15 ng/ml) was assessed by adding IL-6 (20 ng/ml) (I1395, Sigma) the effect of control (5%) or CD (5%) rat serum was also assessed. PC (0.2 mg/ml) was administered after cell seeding.
Preparation of hepatocyte mitochondria and cytoplasm fractions
Mitochondria-enriched fractions were obtained following the procedure described by Magalhâes et al. 21 from control and CD diet hepatocytes. Hepatocytes were collected, disrupted in ice-cold lysis buffer (2 mM HEPES, 0.15 mM MgCl 2 , 10 mM KCl, 0.5 mM EGTA, and protease inhibitors) with a Dounce homogenizer, and adjusted to 0.32 M final sucrose concentration. Cell debris and nuclei were removed by centrifugation at 1000 g for 5 min. Crude mitochondria were obtained by centrifugation of supernatant at 10,000 g for 10 min, and layered onto a discontinuous sucrose gradient established with 0.8, 1.0, 1.2, 1.4, and 1.6 M sucrose concentrations in 2 mM HEPES buffer, pH 7.4. After centrifugation at 95,000 g for 90 min, the pure mitochondria fraction, located between the 1.2 M and 1.4 M sucrose layers, was recovered. The purified mitochondria were essentially devoid of contaminating organelles, such as lysosomes, endoplasmic reticulum and plasma membrane, as revealed by electron microscopy of fixed preparations (data not shown). The low amount of mitoplasts in the fraction located between the 1.4 M and 1.6 M sucrose layers indicated the preservation of mitochondrial integrity during the purification procedure. In addition, mitochondrial enrichment was confirmed by the high expression of pyruvate dehydrogenase component E2 (PDC-E2, Santa Cruz Biotechnology; data not shown) and reduced b-actin expression ( Fig. 8 ). The cytoplasmic fraction of hepatocytes was prepared according to Schreiber et al. 22 Isolation of RNA and quantitative real-time RT-PCR procedure
Total RNA was extracted from hepatocytes using Trizol reagent according to the manufacturer's recommendations (Invitrogen, Carlsbad, CA, USA). The expression of mRNA for IL-6 receptor (IL-6R) gp80 binding domain was examined by quantitative real-time RT-PCR (Roche Diagnostics, Indianapolis, IN, USA) using as primers 5 0 -CAAAGAACGTTCA CGGTGTG-3 0 and 5 0 -ACTGGCCAATGTCAAACTCC-3 0 , and 18S (MVG-Biotech AG, Sabadell, Spain) as reference. Onestep RT-PCR was performed using QuantiTect SYBR Green RT-PCR kit (Qiagen, Hilden, Germany), as recommended by the manufacturer. The RT conditions were 20 min at 55 C and 15 min at 95 C. The amplification protocol consisted of 50 cycles of incubation after initial denaturation at 95 C for 15 s (20 C/s), 60 C for 30 s (20 C/s) and 72 C for 30 s (2 C/s). The melting conditions were fixed at 65 C (0.1 C/s). Quantification of relative expression was determined by the 2 (ÁCT) method. 23 Lipid analysis of hepatic tissue and mitochondria Phospholipids (PL) and neutral lipids were extracted exhaustively from liver homogenates and mitochondria with chloroform:methanol; the lipids were separated by one-dimensional thin-layer chromatography on EDTAimpregnated Silicagel G-60 plates (Glasschrom, Macherey-Nagel, Germany) with five step-wise developments, as previously described. 24 The lipid spots were quantified by QuantityOne v4.4 software (Bio-Rad, Hercules, CA, USA) using cholesteryl formate (0.2 mg/ ml) as internal standard and standard curves for each of the lipids. The detection ranges were: for cholesterol esters (ChE) 0.03-1.23 nmol, free cholesterol (Ch) 0.06-2.53 nmol, PC 0.09-4.43 nmol, phosphatidylethanolamine (PE) 0.10-3.95 nmol, phosphatidylinositol (PI) 0.08-1.33 nmol, phosphatidylserine (PS) 0.05-1.78 nmol and for cardiolipin (Cln) 0.02-0.69 nmol. The content of triglycerides (TAG) and total cholesterol in liver was measured using commercial assay kits (Cromatest, Montgat, Spain).
Assessment of DNA fragmentation, caspase-3-associated activity, lactate dehydrogenase release and reactive oxygen species production
Hepatocytes were lysed in 100 mM Tris-HCl pH 8.0, 5 mM EDTA, 150 mM NaCl and 0.5% sarkosyl for 10 min at 4 C, and incubated successively with RNAse (50 mg/ml) for 2 h at 37 C and proteinase K (100 mg/ml) for 45 min at 48 C. DNA was extracted with phenol:chloroform:isoamyl alcohol (25:24:1), precipitated with cold isopropanol (1:1) for 12 h at À20 C, and recovered by centrifugation at 20,800 g for 10 min at 4 C. Samples (100 mg DNA) were analyzed on 1.5% agarose gels with 0.5 mg/ml ethidium bromide.
Caspase-3 activity was measured in cytoplasm (25 mg protein) using a peptide-based substrate (Ac-Nacetyl-Asp-Glu-Val-Asp-AFC; Bachem, Bubendorf, Switzerland; 100 mM) in 50 mM HEPES pH 7.5, 100 mM NaCl, 10% sucrose, 0.1% CHAPS, 1 mM EDTA and 5 mM DTT. The increase in fluorescence was recorded in a GENios Reader (TECAN, Salzburg, Austria), using excitation wavelength of 400 nm and emission 505 nm.
Lactate dehydrogenase (LDH) activity was assessed in the culture medium and cytoplasm by incubation with 0.2 mM NADH and 0.4 mM pyruvate in PBS pH 7.4, followed by reading the absorbance at 334 nm. The LDH release represents the percentage activity in the culture medium in relation to total LDH.
Reactive oxygen species (ROS) production was monitored by 2 0 ,7 0 -dichlorofluoresceindiacetate fluorescence (Molecular Probes, Leiden, The Netherlands). Hepatocytes were incubated with 2 mM 2 0 ,7 0 -dichlorofluoresceindiacetate for 30 min and then with 10 mM digitonin for 5 min in order to eliminate any probe not retained in mitochondria. Fluorescence was assessed in situ in a GENios Reader (excitation 500 nm, emission 520 nm).
Analysis by Western blot of cytochrome-c release and hepatic TNF-a expression
The expression of cytochrome-c was estimated in cytoplasm and mitochondria. Proteins (5 mg) were separated by 12% SDS-PAGE and transferred to nitrocellulose membranes. The membranes were incubated with primary rabbit polyclonal antibodies against cytochrome-c (sc-7159) and secondary antibodies, coupled with horseradish peroxidase (sc-2301), revealing protein bands with ECL (all from Santa Cruz Biotechnology).
For assessing the hepatic expression of TNF-a, frozen livers (0.5 g) were homogenised (Ultra-turrax T25, Janke and Kunkel, IKA Laboratory) in lysis solution (50 mM HEPES pH 7.5, 2 mM EDTA, 100 mM NaCl, 1% (v/v) NP-40, 1 mM PMSF, 5 mg/ml aprotinin and 10 mg/ml leupeptin). Proteins (100 mg) were processed as described above and membranes probed with goat polyclonal anti-rat TNF-a antibodies (AF-510-NA, R&D Systems) and secondary horseradish peroxidasecoupled antibodies (Santa Cruz Biotechnology). TNF-a (Sigma) was used as a positive control.
Activity of the mitochondrial electron transport complexes
Mitochondria-enriched fractions were used to determine complexes I, II, III, I þ III, II þ III, and IV activities. 25 Complex I activity was determined as the NADHdependent consumption rate in the presence or not of rotenone. Complex II activity was measured by the reduction of 2,6-dichlorophenolindophenol. The complex III activity was assayed by cytochrome-c reduction in the presence or not of antimycin A. Cytochrome-c oxidase (complex IV) activity was determined as the rate of oxidation of reduced cytochrome-c. The activity of complexes IþIII and IIþIII was estimated as the NADH-and the succinate-dependent cytochrome-c reduction, respectively.
Statistical analysis
Results are expressed as mean AE SE of 5 or 6 experiments. Data were compared using ANOVA with the Least Significant Difference (LSD) test as post-hoc multiple comparison analysis. The statistical significance was set at P 0.05.
RESULTS
Hepatic lipid profile and histology and serum IL-6 levels
The CD diet markedly increased TAG ( Fig. 1A ) and total cholesterol (Fig. 1B) , and reduced PC (Fig. 1C ) and PE ( Fig. 1D ) in livers (P 0.05, at least). Interestingly, the PC:PE molar ratio, which is considered to be a membrane integrity marker, 26 diminished as the CD diet feeding period extended and steatosis progressed to 1.67 AE 0.10 (P 0.05), 1.27 AE 0.09 (P 0.01) and 1.20 AE 0.07 (P 0.01) within 3, 7 and 14 d on a CD diet, while in control rats the PC:PE ratio remained constant (2.16 AE 0.08, 2.20 AE 0.10 and 2.49 AE 0.13). After 28 days or 42 d of CD feeding, the hepatic concentration of TAG steeply increased, whereas PC and PE remained close to the 14-d levels (data not shown). It is also worthy of note that while free cholesterol did not accumulate in liver, both the net mass of ChE, the storage form of cholesterol (data not shown), and its contribution to total cholesterol increased gradually over the 42 d of CD feeding (the ChE mol percentage averaged 13.1 AE 0.8 in control rats taken together and rose to a value ranging from 16.5 AE 1.2 (3 d) to 60.0 AE 4.8 (42 d) in CD animals).
Although it has been described that CD induces liver microvesicular steatosis, 19 we observed the presence of microvesicular (3 d) and macrovesicular (14 d) lipid droplets in CD liver sections (Fig. 2 ). We could not detect signs of apoptosis, such as TUNEL-positive cells, in CD liver sections (Fig. 2) . Nevertheless, hepatic damage, as assessed by serum ALT activity, rose dramatically after 14 d of CD feeding, but not after 3 d or 7 d (Fig. 3A) , and maintained elevated at days 28 and 42 (data not shown). The measurement of serum glucose and insulin concentrations showed that CD diet did not induce insulin resistance, as assessed by the Homeostasis Model Assessment (HOMA) index (data not shown). The gain in body weight was not altered by the diet. Tumor necrosis factor-a was undetectable in blood (52.3 pg/ml) from CD animals. The expression of TNF-a was very low in liver and unaffected by the CD diet ( Fig. 4) . Nevertheless, the concentration of IL-6, which decreased modestly at day 3, increased sharply at 14 d in CD animals (Fig. 3B) , and maintained elevated at days 28 and 42 (data not shown). Regression analysis of serum IL-6 and liver TAG levels in this model of hepatic steatosis showed that these two parameters are strongly and positively correlated ( Fig. 3C ).
Hepatocytes are target cells of IL-6
After isolation, CD hepatocytes elicited marked steatosis, with elevated concentrations of TAG (111 AE 10 vs 21 AE 8 nmol/mg cell protein; P 0.05) and total cholesterol (11 AE 2.5 vs 5 AE 1.9 nmol/mg cell protein; P 0.05), as compared with cells isolated from control diet fed rats. Choline-deficient hepatocytes showed an almost 5-fold IL-6R mRNA expression (6 h; Fig. 5A ). We were not able to detect IL-6 mRNA expression in hepatocytes (data not shown). The addition of blood serum from steatotic CD rats, but not from control animals, further enhanced the expression of IL-6R mRNA in CD hepatocytes (Fig. 5B) , and a similar, though delayed (12 h), effect was seen in control cells (Fig. 5C ). Neither control nor CD serum addition affected the cellular TAG content of control and CD hepatocytes (data not shown). 
Effect of exogenous IL-6 and PC on mitochondrial disturbances induced by choline deficiency
As seen in Figure 1 , the reduction of PC and PE content and of the PC:PE ratio was associated with the accumulation of TAG and total cholesterol (particularly ChE) in liver homogenates from CD animals. Nevertheless, the measurement of phospholipid and neutral lipid classes in hepatocyte mitochondria showed a selective CD-promoted lipid imbalance ( Table 2 ). Choline deficiency enhanced TAG, Cln and, surprisingly, also PC, while reduced PS and PI content in mitochondria. The PC:PE molar ratio was, therefore, increased in CD mitochondrial membranes by about 70%. Under this condition, the free Ch and ChE contents in mitochondria was rather unaffected (Table 2) , though the percentage of cholesterol in its storage, esterified form rose by 20% (data not shown). It is recognized that the activity of several mitochondrial electron transport chain (ETC) components is dependent on specific membrane lipid interactions. 27 We found that the disturbed mitochondrial lipid composition did affect ETC activity (Fig. 6) . The administration of CD diet markedly enhanced the activity of complex I, and moderately those of complexes II and III (Fig. 6 ). The free radical-sensitive activities of complexes IþIII and complexes IIþIII suffered a great reduction by CD diet (Fig. 6) . Also, the activity of complex IV in CD mitochondria was one half that measured in mitochondria from non-steatotic hepatocytes.
The generation of ROS in mitochondria due to impaired ETC activity, is relevant for the induction of cell death in hepatocytes. 28 In our hands, CD hepatocytes showed higher ROS production and susceptibility to TNF-a-induced cell death as compared with the control hepatocytes ( Fig. 7) . Interleukin-6 has been reported to exert cytoprotective properties in hepatocytes. [29] [30] [31] We then evaluated the effect of IL-6 on TNF-a-induced cell death in control and CD hepatocytes. The CD diet per se induced a modest DNA fragmentation ( Fig. 8A ) and unaffected caspase-3 activity (Fig. 8B) . Nevertheless, CD hepatocytes were vulnerable to TNF-a challenge (Fig. 8A,B) . These effects were not modified by IL-6 but, however, were counteracted by addition of PC. We also measured cytochrome-c protein expression in the cytoplasm and mitochondria of control and CD hepatocytes (Fig. 8C) .
The densitometric analysis showed that cytochrome-c release was higher in CD than in control hepatocytes (2.52 AE 0.15 vs 1.99 AE 0.22; P 0.05). Interleukin-6 did not reduce the TNF-a-induced cytochrome-c release in CD hepatocytes. Neither did the removal of IL-6 from added CD rat serum alter cellular apoptosis in hepatocytes (data not shown). In contrast, the addition of PC abrogated cytochrome-c release, most markedly in CD hepatocytes (from 2.52 AE 0.15 to 0.70 AE 0.05; P 0.05). Therefore, IL-6 did not ameliorate the TNF-a-inducible responses measured here, while PC did. We next analyzed whether such findings were associated with changes in the mitochondrial lipid profile ( Table 3 ). Treatment with TNF-a did not result in substantial changes of mitochondrial lipid levels, with the exception of a 50% rise in PI in the two diet groups (compared with the values in Table 2 ). We found that IL-6 counteracted the CD diet-promoted rise in PC in mitochondria, and recovered the PC:PE molar ratio of control cells. In addition, IL-6 diminished PI, Cln and TAG concentrations in CD hepatocyte mitochondria, showing the organelle of control cells almost super imposable changes. However, PC supplementation did not affect the mitochondria lipid profile.
DISCUSSION
Liver steatosis is relevant for the progression of NAFLD. The involvement of IL-6 in lipid homeostasis and cell death have been addressed using in vivo and in vitro approaches in a rodent CD diet model of hepatic steatosis. Choline deficiency increased TAG and total and esterified cholesterol, and reduced PC and PE content and the PC:PE ratio in liver. In isolated hepatocyte mitochondria, however, CD enhanced PC, TAG, Cln and the PC/PE ratio, but reduced PS and PI, and impaired ETC activity. The CD-induced alteration in liver lipid composition was associated with high peripheral IL-6 levels, as well as with IL-6R transcript expression rise. The cell treatment with IL-6 eliminated most of the effect of CD diet on mitochondria PC content and PC:PE ratio, but did not modify the CD-induced exacerbation of cell death in TNF-a-treated hepatocytes, which was relieved, however, by exogenous PC addition.
Fatty liver or hepatic steatosis is a common histological finding in human liver biopsy specimens. 32 The adverse effect of steatosis has been observed in liver transplantation and resection, 33 as well as after alcohol or toxin insults. 34, 35 Phosphatidylcholine is present in a high concentration on the plasma membrane of most mammalian cells, 36 and it is absolutely required for hepatic VLDL assembly and secretion. 37 A current model of hepatic steatosis is to feed rodents a CD diet. 38, 39 Choline deprivation reduces the CDP-choline pathway for PC synthesis in rat liver. 40 In the liver, PC is also synthesized by methylation of PE by PE N-methyltransferase (PEMT) using S-adenosylmethionine as the methyl donor. 41 Hepatocytes were isolated from rats fed a control or a cholinedeficient (CD) diet for 3 d, and cultured in control or in CD medium, respectively, for 24 h. Mitochondria were then isolated, and the concentration nmol/mg protein of triglycerides (TAG), free cholesterol (Ch), cholesterol esters (ChE), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI), and cardiolipin (Cln) was determined as described in Materials and Methods. Results are expressed as mean AE SE of six independent experiments. Statistical significance was set at P 0.05. a Significant differences versus the control diet group. Effect of a choline-deficient diet on the electron transport chain (ETC) activity in hepatocyte mitochondria. Hepatocytes were isolated from rats fed a control or a choline deficient (CD) diet for 3 d, and cultured in control or in CD medium, respectively, for 24 h. Mitochondria were then isolated and the ETC activities were determined as described in Material and Methods. Results are expressed as mean AE SE of five independent experiments. Statistical significance was set at P 0.05. b Significant differences versus the counterpart complex in control rat mitochondria.
In rodents, this pathway accounts for $30% of hepatic PC biosynthesis. 42 It has been demonstrated in CD-Pemt -/mice, that a decrease in the PC:PE ratio, rather than in net PC levels, influences membrane integrity and is involved in the progression of steatosis into steatohepatitis. 26 We observed that within a few days (3) of choline restriction, the progressive accumulation of TAG and cholesterol in CD rat liver was paralleled by a progressive reduction in the PC:PE ratio of up to 50%, which was not sustained by PE methylation. However, PC homeostasis in rodents is complex. 42 Mice seem to be more resistant and adapt to choline deficiency more rapidly than the rat, as normal liver levels of PC and hepatocyte PC synthesis rate were recorded in mice after 21 days of CD feeding. 43 Our results are in line with findings in NASH patients, where the hepatic PC:PE ratio was found to be lower than in healthy subjects. 26 We observed that the CD diet at day 3 enhanced Cln, a phospholipid required for optimal activity of complex I, and PC and the PC:PE ratio, and reduced PS and PI in hepatocyte mitochondria. The rise of PC and Cln may be relevant for the dramatic increase of complex I activity found in CD mitochondria. The CD diet moderately increased the activities of complexes II and III in mitochondria. This alteration was related to a rise of ROS production, and reduced complexes IþIII and complexes IIþIII activities, associated with higher susceptibility to cytochrome-c release in CD mitochondria. The stability of coenzyme Q, a key component for electron transport to complex III, is highly susceptible to oxidative stress. 44 Since the accumulation of PC was not associated with a decrease of mitochondrial PE, our findings suggest at first that both PC and PE redistributed from other cell membranes to mitochondria. Petrosillo et al. 27 observed that the complex I activity failure was related to PC and Cln reduction in hepatocyte mitochondrial fraction from rats fed CD diet for 30 days. Together with ours, these findings suggest that complex I dysfunction in rats with non-alcoholic fatty liver is associated with rapid increases followed by mediumterm reductions of mitochondrial PC and Cln. Also, they suggest a timely precise control of lipid metabolism and distribution in mitochondria biogenesis in hepatocytes, at least under choline scarcity conditions. The CD model causes a predominant TAG accumulation in hepatocytes and mitochondria. In an elegant study by Marí et al., 45 hepatocytes from CD-rats (2 d) were found to elicit a modest susceptibility to TNF-a to enhance apoptotic and necrotic markers without signs of liver and mitochondria cholesterol accumulation. The authors also found that cholate-supplemented hypercholesterolemic diet fed rats showed mitochondrial GSH depletion and enhanced TNF-a susceptibility to cell death in hepatocytes and proved this to be associated with liver and mitochondrial Ch accumulation. 45 In our conditions, CD hepatocytes (3 d) did not accumulate cholesterol in mitochondria but did it (ChE) in the cytoplasm and showed an enhanced susceptibility to cell death characterized by enhanced ROS production, DNA fragmentation, mitochondrial cytochrome-c release and LDH release. It seems likely that the fact that ChE accumulates in liver after 3 d ( Fig. 1 ) but not after 2 d 45 of feeding animals with CD diet may be related to homeostatic/compensation processes that affect cholesterol storage and are triggered when choline deprivation reaches a threshold value.
Recent evidence suggests that innate immune disorders are involved in the induction and/or progression of obesity and insulin resistance. 46 In particular, Hepatocytes were isolated from rats fed a control or a CD diet for 3 days, and cultured in control or in CD medium, respectively, for 12 h. The production of ROS was monitored by 2 0 ,7 0 -dichlorofluoresceindiacetate fluorescence in cells challenged with TNF-a (10 ng/ml) and actinomycin A (15 ng/ml) or solvent only. Lactate dehydrogenase activity was measured in cells and medium, and LDH release assumed to be 100% in untreated control hepatocytes. Reactive oxygen species production in control cells was 212 AE 35.7 arbitrary units. Lactate dehydrogenase release in control cells was 17 AE 3.0%. Results are expressed as mean AE SE of five independent experiments. Statistical significance was set at P 0.05. a Significant differences versus the corresponding control in the same diet; b significant differences versus the counterpart group with control diet.
pro-inflammatory cytokines, such TNF-a and IL-6, have been shown to play a role in insulin resistance through the disruption of early insulin-stimulated tyrosine phosphorylation events, which is crucial to insulin transmembrane signalling, in cultured hepatocytes. 47, 48 In our experimental conditions, choline deprivation induced an increase of IL-6 concentration in blood ( Fig. 3) and of IL-6R transcript expression ( Fig. 5 ) and TAG concentration ( Fig. 1) in liver, but the animals did not present signs of insulin resistance. Moreover, IL-6 mRNA expression could not be detected in control and CD hepatocytes (data not shown). Therefore, intracellular lipid accumulation and high circulating IL-6 levels are not necessary factors for insulin resistance occurrence. Although hepatic steatosis, in animals and in humans, is strongly associated with a decrease in insulin sensitivity, a large variability in this relationship exists that cannot be explained by other parameters regulating insulin sensitivity such as overall obesity, body fat distribution or circulating adipokines. 49 This discrepancy has been related to the existence of lipotoxicity based on the accumulation of free fatty acids. The incorporation of fatty acids into triglycerides, as well as their oxidative degradation, may be thus regarded as a protection mechanism from lipotoxicity. 49 Tumornecrosis factor-a was undetectable in blood from CD rats that agrees with a study by Nieto and Rojkind 50 in which CD reduced serum TNF-a levels. The expression of TNF-a in the liver, as measured by immunohistochemistry and Western-blot analysis, was very low and the levels were not essentially modified by the diet. In our conditions, the increased peripheral IL-6 concentration may be of extrahepatic origin. Recently, Sabio et al. 51 have shown that secretion of IL-6 by adipose tissue is related to hepatic insulin resistance in a high-fat mouse model of metabolic stress. There are strong clinical and experimental evidences supporting a role for IL-6 in liver lipid homeostasis, although some results are conflicting. A rise in serological IL-6 has been associated with hepatic steatosis in obese morbid 16 and NASH 17 patients. However, IL-6 has also been suggested to ameliorate fatty livers and protect against ischemia/reperfusion fatty liver injury, 52 and to mediate pharmacological reduction of hepatic steatosis. 18 Also, the increase in circulating IL-6 by matrix metalloproteinase inhibitor is related to prevention of dietary-induced hepatic steatosis. 18 In experiments performed in cultured rat hepatocytes, it was found that IL-6 promotes apoB mRNA expression and VLDL secretion, 53 as did the IL-6-rich Kupffer cell conditioned medium, 54 which might be beneficial for steatosis. Also, a beneficial effect for IL-6 has been suggested in intestinal epithelial cell cultures, promoting the release of secretory phospholipase A 2 and altering the cellular PL composition and membrane integrity. 55 Phospholipase A 2 -mediated hydrolysis of PC induced by IL-6 has been reported to occur in anterior pituitary cells. 56 We found that exogenous application of PC did not essentially change the phospholipid and the neutral lipid composition in mitochondrial fraction from TNF-a-treated hepatocytes. However, IL-6 reduced the content of PC, TAG and Cln induced by the CD diet in the hepatocyte mitochondria, and cytochrome-c release (C). Hepatocytes were isolated from rats fed a control or a CD diet for 3 d, and cultured in control or in CD medium, respectively, for 24 h. When noted, cell death was induced by TNF-a (10 ng/ml) and actinomycin A (15 ng/ml) addition to cultures, and IL-6 (20 ng/ml) or PC (0.2 mg/ml) was added. DNA fragmentation in cell lysates was analyzed on 1.5% agarose gels with ethidium bromide (0.5 mg/ml); caspase-3 activity was determined in the cell cytoplasm using a peptide-based substrate assay; and cytochrome-c protein release was determined in hepatocyte mitochondria and cytoplasm fractions. Results are expressed as mean AE SE of five independent experiments. Statistical significance was set at P 0.05. a Significant differences versus the corresponding control in the same diet; b significant differences versus the counterpart group with control diet.
The images are representative of five independent experiments.
indicating that IL-6 eliminated much of the lipid disturbances induced by CD in hepatocytes through a mechanism that may involve cellular PC hydrolysis but that cannot be alleviated by exogenous PC.
Interleukin-6 has been shown to exert in vivo and in vitro cytoprotective properties in hepatocytes. [29] [30] [31] The CD diet exacerbated TNF-a-induced apoptosis in cultured hepatocytes. The exogenous addition of IL-6 did not modify the apoptotic cell signal exacerbated by CD in TNF-a-treated hepatocytes. Interleukin-6 has been shown to confer protection and initiate hepatocyte proliferation in different experimental models. 57 In steatotic rats, impaired liver regeneration was found to be associated with interruption in the normal IL-6 signaling pathway, a critical pathway that primes the hepatocytes to respond to mitogenic signals. 58 Exogenous application of PC has been demonstrated to exert anti-inflammatory effects in enterocyte cell line 59 related to reduced inflammatory response in the gut. 60 The evaluation of different relevant cell death markers shows that PC is effective at counteracting the CD diet exacerbation of TNF-a-induced apoptosis in hepatocytes.
CONCLUSIONS
The CD diet induced an increase in serological IL-6 concentration that was accompanied by progressive hepatic neutral lipid accumulation and PC:PE ratio decrease, with mitochondrial dysfunction and enhanced susceptibility to cell death in hepatocytes. The study indicates that exogenous IL-6 counteracts much of the effects of choline deficiency on mitochondrial lipids, but it does not affect hepatocyte survival. The cytoprotective role of extracellular PC emerges as an interesting topic that deserves to be pursued in future work. 
